Prosecution Insights
Prosecution Insights
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FIDLER, SHELBY LEE | 1 | 79.0% | +14.7% |
| BERTRAM, ERIC D | 1 | 81.0% | +12.6% |
| BAUSCH, SARAE L | 1 | 29.0% | +43.8% |
| SCHMITT, MICHAEL J | 1 | 56.6% | +21.7% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18561999 | BIO-IMPLANTABLE BLADDER TREATMENT DEVICE, AND METHOD FOR MANUFACTURING ELECTRONIC WEB AND ELECTRONIC THREAD INCLUDED THEREIN | BERTRAM, ERIC D | 23d |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18039563 | PCR KIT FOR DIAGNOSING ASTHMA OR ASTHMA EXACERBATION AND METHOD FOR PROVIDING INFORMATION FOR DIAGNOSING ASTHMA OR ASTHMA EXACERBATION BY USING SAME | BAUSCH, SARAE L | 33d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18561999 | BIO-IMPLANTABLE BLADDER TREATMENT DEVICE, AND METHOD FOR MANUFACTURING ELECTRONIC WEB AND ELECTRONIC THREAD INCLUDED THEREIN | BERTRAM, ERIC D | 23d |
| 17744162 | USE OF SILDENAFIL AND ROCK INHIBITORS FOR TREATING STROKE OR SEQUELAE FOLLOWING STROKE | SCHMITT, MICHAEL J | 30d |
| 18039563 | PCR KIT FOR DIAGNOSING ASTHMA OR ASTHMA EXACERBATION AND METHOD FOR PROVIDING INFORMATION FOR DIAGNOSING ASTHMA OR ASTHMA EXACERBATION BY USING SAME | BAUSCH, SARAE L | 33d |
| 18666247 | INKJET PRINTING SYSTEM | FIDLER, SHELBY LEE | 71d |
| Art Unit | Apps |
|---|---|
| 2853 | 1 |
| 3796 | 1 |
| 1699 | 1 |
| 1629 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18666247 | INKJET PRINTING SYSTEM | FIDLER, SHELBY LEE | 2853 | §103 | Non-Final OA | 71d | Pending | May 16, 2024 |
| 18561999 | BIO-IMPLANTABLE BLADDER TREATMENT DEVICE, AND METHOD FOR MANUFACTURING ELECTRONIC WEB AND ELECTRONIC THREAD INCLUDED THEREIN | BERTRAM, ERIC D | 3796 | §103 | Non-Final OA | 23d | Pending | Nov 17, 2023 |
| 18039563 | PCR KIT FOR DIAGNOSING ASTHMA OR ASTHMA EXACERBATION AND METHOD FOR PROVIDING INFORMATION FOR DIAGNOSING ASTHMA OR ASTHMA EXACERBATION BY USING SAME | BAUSCH, SARAE L | 1699 | §103 | Final Rejection | 33d | Pending | May 31, 2023 |
| 17744162 | USE OF SILDENAFIL AND ROCK INHIBITORS FOR TREATING STROKE OR SEQUELAE FOLLOWING STROKE | SCHMITT, MICHAEL J | 1629 | §103 | Non-Final OA | 30d | Pending | May 13, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial